Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Genfit Assesses Optimal Elafibranor NASH Combo Therapy Opportunity
Jun 24 2019
•
By
Joseph Haas
Based in Lille, France, Genfit is one of five companies to reach Phase III in NASH
More from Strategy
More from Business